Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Inhibitors of Schistosoma mansoni HDAC8 by Combining Homology Modeling, Virtual Screening, and in Vitro Validation
Srinivasaraghavan Kannan, Jelena Melesina, Alexander‐Thomas Hauser, et al.
Journal of Chemical Information and Modeling (2014) Vol. 54, Iss. 10, pp. 3005-3019
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta, Devesh Srivastava, Mehar Sahu, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1315-1360
Open Access | Times Cited: 889
HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti, Ina Oehme, Olaf Witt, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 7, pp. 481-492
Open Access | Times Cited: 240
Decision Making in Structure-Based Drug Discovery: Visual Inspection of Docking Results
André Fischer, Martin Smieško, Manuel Sellner, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2489-2500
Closed Access | Times Cited: 183
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis
Tino Heimburg, Alokta Chakrabarti, Julien Lancelot, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 6, pp. 2423-2435
Open Access | Times Cited: 117
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Chiara Zagni, Giuseppe Floresta, Giulia Monciino, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1373-1428
Closed Access | Times Cited: 117
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Alokta Chakrabarti, Jelena Melesina, Fiona R. Kolbinger, et al.
Future Medicinal Chemistry (2016) Vol. 8, Iss. 13, pp. 1609-1634
Open Access | Times Cited: 95
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives
Gebremedhin Solomon Hailu, Dina Robaa, Mariantonietta Forgione, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 12, pp. 4780-4804
Closed Access | Times Cited: 93
Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina, Conrad V. Simoben, Lucas Praetorius, et al.
ChemMedChem (2021) Vol. 16, Iss. 9, pp. 1336-1359
Closed Access | Times Cited: 84
Natural Products as Leads in Schistosome Drug Discovery
Bruno J. Neves, Carolina Horta Andrade, Pedro Cravo
Molecules (2015) Vol. 20, Iss. 2, pp. 1872-1903
Open Access | Times Cited: 85
Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties
Jefferson Almeida Rocha, Nayra C. S. Rego, Bruna T. S. Carvalho, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0198476-e0198476
Open Access | Times Cited: 63
Structure of ‘linkerless’ hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket
Alexa A. Tabackman, Rochelle Frankson, Eric S. Marsan, et al.
Journal of Structural Biology (2016) Vol. 195, Iss. 3, pp. 373-378
Open Access | Times Cited: 59
Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening
Fanwang Meng, Su-Fang Cheng, Hong Ding, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 20, pp. 8166-8181
Closed Access | Times Cited: 58
High Throughput and Computational Repurposing for Neglected Diseases
H. Hernandez, Melinda Soeung, Kimberley M. Zorn, et al.
Pharmaceutical Research (2018) Vol. 36, Iss. 2
Open Access | Times Cited: 50
Opportunities and Difficulties in the Repurposing of HDAC Inhibitors as Antiparasitic Agents
Tapas Kumar Mohapatra, Reena Rani Nayak, Ankit Ganeshpurkar, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 70-101
Open Access | Times Cited: 5
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
Conrad V. Simoben, Dina Robaa, Alokta Chakrabarti, et al.
Molecules (2018) Vol. 23, Iss. 3, pp. 566-566
Open Access | Times Cited: 43
Chemotherapy for Fighting Schistosomiasis: Past, Present and Future
Patrick Mäder, Georg Alexander Rennar, Alejandra M. Peter Ventura, et al.
ChemMedChem (2018) Vol. 13, Iss. 22, pp. 2374-2389
Closed Access | Times Cited: 40
Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors
Jelena Melesina, Dina Robaa, Raymond J. Pierce, et al.
Journal of Molecular Graphics and Modelling (2015) Vol. 62, pp. 342-361
Closed Access | Times Cited: 40
Post-translational Modifications of Trypanosoma cruzi Canonical and Variant Histones
Gisele Fernanda Assine Picchi, Vanessa Zulkievicz, Marco Aurélio Krieger, et al.
Journal of Proteome Research (2017) Vol. 16, Iss. 3, pp. 1167-1179
Closed Access | Times Cited: 38
Target-Based Molecular Modeling Strategies for Schistosomiasis Drug Discovery
Leonardo L. G. Ferreira, Glaucius Oliva, Adriano D. Andricopulo
Future Medicinal Chemistry (2015) Vol. 7, Iss. 6, pp. 753-764
Closed Access | Times Cited: 36
Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors
Zsófia Kutil, Jana Mikešová, Matthes Zessin, et al.
ACS Omega (2019) Vol. 4, Iss. 22, pp. 19895-19904
Open Access | Times Cited: 34
Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni
Elisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 7, pp. 1356-1366
Open Access | Times Cited: 18
Metalloenzyme Inhibitors against Zoonotic Infections: Focus on Leishmania and Schistosoma
Sara Rossi, Valeria Tudino, Gabriele Carullo, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1520-1535
Closed Access | Times Cited: 3
Discovery of Fungal Denitrification Inhibitors by Targeting Copper Nitrite Reductase from Fusarium oxysporum
Masaki Matsuoka, Ashutosh Kumar, Muhammad Muddassar, et al.
Journal of Chemical Information and Modeling (2017) Vol. 57, Iss. 2, pp. 203-213
Closed Access | Times Cited: 31
Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening
Yan Ye, Bidong Zhang, Ruifeng Mao, et al.
Organic & Biomolecular Chemistry (2017) Vol. 15, Iss. 17, pp. 3648-3661
Closed Access | Times Cited: 29
Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents
Fulvio Saccoccia, Margherita Brindisi, Roberto Gimmelli, et al.
ACS Infectious Diseases (2019) Vol. 6, Iss. 1, pp. 100-113
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top